Ionis Pharmaceuticals, Inc. (IONS)

81.02 +2.49 (+3.17%) USD  |  NASDAQ  |  Jan 06, 15:46
More

Ionis Pharmaceuticals Research and Development Expense (Annual): 901.53M for Dec. 31, 2024

Research and Development Expense (Annual) Chart

View Research and Development Expense (Annual) for IONS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Annual) Range, Past 5 Years

View Research and Development Expense (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Annual) Benchmarks

View Research and Development Expense (Annual) Benchmarks
Start Trial
Eli Lilly & Co. 10.99B
Merck & Co., Inc. 15.79B
Pfizer Inc. 10.74B
Cogent Biosciences, Inc. 228.26M
Perspective Therapeutics, Inc. 39.33M